Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Trial of the ALK Grass Tablet in Subjects With Hayfever

This study has been completed.
Information provided by (Responsible Party):
ALK-Abelló A/S Identifier:
First received: September 26, 2005
Last updated: January 28, 2013
Last verified: January 2013